- $30.87bn
- $32.23bn
- $7.36bn
- 92
- 21
- 94
- 78
Annual cashflow statement for Xylem, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 401 | 254 | 427 | 355 | 609 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 199 | 142 | -8 | 171 | 82 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 59 | 208 | -136 | -102 | -211 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 839 | 824 | 538 | 596 | 837 |
| Capital Expenditures | -226 | -183 | -208 | -208 | -271 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -5 | 14 | 25 | 17 | -357 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -231 | -169 | -183 | -191 | -628 |
| Financing Cash Flow Items | -3 | -2 | -3 | -2 | -13 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -177 | 473 | -855 | -790 | -157 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 428 | 1,151 | -526 | -405 | 75 |